In a Tuesday letter, nongovernmental organization Knowledge Ecology International, Universities Allied for Essential Medicines, and the Union for Affordable Cancer Treatment urged the Department of Health and Human Services to license patents on the drug Xtandi to outside manufacturers to produce lower-cost versions of the drug.
Latest attempt at getting government to help cut Xtandi costs
Industry fighting administration over drug pricing plans
The Biden administration is facing a new call to use its government authority to license an Astellas and Pfizer prostate cancer drug for generic manufacturing.
